Guanabenz
Back to searchScientific Name: | Guanabenz |
Brand Name: | Not Available |
Company Owner: | Ivax pharmaceuticals inc sub teva pharmaceuticals usa, Sandoz inc, Teva pharmaceuticals usa, Watson laboratories inc, Wyeth ayerst laboratories |
Mechanism Of Action | Guanabenz’s antihypertensive effect is thought to be due to central alpha-adrenergic stimulation, which results in a decreased sympathetic outflow to the heart, kidneys, and peripheral vasculature in addition to a decreased systolic and diastolic blood pressure and a slight slowing of pulse rate. Chronic administration of guanabenz also causes a decrease in peripheral vascular resistance. |
Description of the Drug: | Guanabenz is an alpha-2 adrenergic agonist used to treat hypertension. |
Protein Data Bank: | Not Available |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB00629